Solt DB Invest shows you how much biotech stocks need to rise or fall in real time to reach our modeled price target. This is called the Margin of Safety.
By quantifying our research in a simple dashboard, it's available whenever you are.
We remove the guesswork and emotions from biotech investing. Solt DB Invest modeling independently predicts the attractiveness of biotech stocks as a whole.
For example, only two stocks we cover are in the top 50 holdings of the SDPR S&P Biotech ETF $XBI, but our overall coverage ecosystem often signals the highs and lows of $XBI to within a few days.
The predictive power of our overall coverage ecosystem is driven by accurate modeling of individual biotech businesses.
Solt DB uses the same illustration tools as scientists publishing in the world's top journals -- a first in finance.
The combination of simple language and clear visuals allows investors of all backgrounds to more deeply understand the biotech stocks they own, while scientists can gain a better grasp of the business of biotech.